Opendata, web and dolomites

HydroPLAST

A hydrophilic polymer material

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

Project "HydroPLAST" data sheet

The following table provides information about the project.

Coordinator
JONSMAN INNOVATION APS 

Organization address
address: HOVEDVEJEN 1d
city: GORLOSE
postcode: 3330
website: www.joninn.com

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Denmark [DK]
 Project website http://www.joninn.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-06-01   to  2018-09-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    JONSMAN INNOVATION APS DK (GORLOSE) coordinator 50˙000.00

Map

 Project objective

The Danish SME Jonsman Innovation ApS will target a major market opportunity through the market introduction of a new thermoplastic polymer (Tensistat) that creates truly hydrophilic devices right after injection moulding or extrusion. Like other thermoplastic materials, Tensistat can be used for many applications, but our R&D focus was to develop the best polymer for applications where hydrophilicity is mandatory for performance and safety (e.g. single-use medical devices such as diagnostic consumables, tubing for injectors, catheters and microfluidic devices). As devices produced with Tensistat are hydrophilic directly from the moulding machine, no post-processing, e.g. hydrophilic coatings are needed, meaning cheaper, safer and more reliable devices. By ensuring and demonstrating a maximum level of effectiveness and complying with the regulatory requirements, we will attain a key differentiating factor in order to gain access to the market. Initially, this will require a Phase 1 feasibility study that will give us a clear direction for our demonstration and market introduction strategies. Later, based on proven feasibility, in the Phase 2 project we will gather the necessary documentation to reach regulatory approval, so Tensistat can be used in the manufacturing of medical and microfluidics devices. Still, we will demonstrate the technical and economic benefits of Tensistat in these segments, to generate enough consumer confidence and facilitate broader market uptake. If the objectives for Phase 1 and 2 are successfully achieved, we will be favourably positioned towards a very large opportunity for Jonsman Innovation. Accordingly, we foresee a cumulative revenue of more than €29.7 million, 5 years after commercialization of the Tensistat material.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "HYDROPLAST" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "HYDROPLAST" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

DeltaQon (2019)

IOT and cloud computing for online medical analysis service platform

Read More  

HUD (2018)

COMMERCIALIZING THE FIRST HEAD-UP-DISPLAY FOR OFF-HIGHWAY VEHICLES

Read More  

HAC (2019)

ADVANCED TREATMENT OF CONTAMINATED SOIL

Read More